BATTAGLIA, Michele
 Distribuzione geografica
Continente #
NA - Nord America 18.858
EU - Europa 7.775
AS - Asia 7.311
SA - Sud America 1.983
AF - Africa 173
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 10
AN - Antartide 2
Totale 36.125
Nazione #
US - Stati Uniti d'America 18.626
SG - Singapore 3.318
IT - Italia 2.918
CN - Cina 1.842
BR - Brasile 1.744
HK - Hong Kong 1.126
SE - Svezia 969
DE - Germania 827
RU - Federazione Russa 753
UA - Ucraina 727
FI - Finlandia 473
VN - Vietnam 395
GB - Regno Unito 390
FR - Francia 276
IN - India 135
CA - Canada 132
AR - Argentina 116
BE - Belgio 94
BD - Bangladesh 72
IE - Irlanda 69
ID - Indonesia 68
MX - Messico 63
ZA - Sudafrica 59
NL - Olanda 57
IQ - Iraq 52
JP - Giappone 51
PL - Polonia 43
CI - Costa d'Avorio 40
TR - Turchia 40
ES - Italia 34
CH - Svizzera 31
EC - Ecuador 31
CO - Colombia 27
SA - Arabia Saudita 27
IR - Iran 24
VE - Venezuela 24
UZ - Uzbekistan 22
PK - Pakistan 21
LT - Lituania 17
KR - Corea 15
MA - Marocco 15
AE - Emirati Arabi Uniti 14
AT - Austria 13
JO - Giordania 13
RO - Romania 13
CL - Cile 12
EG - Egitto 12
KE - Kenya 12
AZ - Azerbaigian 11
AU - Australia 10
CZ - Repubblica Ceca 10
PE - Perù 9
EU - Europa 8
HN - Honduras 8
PT - Portogallo 8
PY - Paraguay 8
PH - Filippine 7
RS - Serbia 7
UY - Uruguay 7
BG - Bulgaria 6
DZ - Algeria 6
OM - Oman 6
TN - Tunisia 6
ET - Etiopia 5
HR - Croazia 5
IL - Israele 5
JM - Giamaica 5
KZ - Kazakistan 5
LB - Libano 5
NP - Nepal 5
TH - Thailandia 5
AL - Albania 4
BH - Bahrain 4
BO - Bolivia 4
CR - Costa Rica 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
EE - Estonia 4
HU - Ungheria 4
LU - Lussemburgo 4
PA - Panama 4
BB - Barbados 3
BY - Bielorussia 3
GR - Grecia 3
PS - Palestinian Territory 3
TW - Taiwan 3
AM - Armenia 2
AQ - Antartide 2
BN - Brunei Darussalam 2
CY - Cipro 2
GA - Gabon 2
LY - Libia 2
MK - Macedonia 2
MT - Malta 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
QA - Qatar 2
SN - Senegal 2
TT - Trinidad e Tobago 2
Totale 36.092
Città #
Fairfield 2.021
Chandler 1.721
Singapore 1.706
Ashburn 1.656
Jacksonville 1.619
Woodbridge 1.433
Hong Kong 1.120
Houston 876
Seattle 858
Cambridge 767
Wilmington 708
Nyköping 663
Ann Arbor 636
Beijing 517
Lawrence 415
Roxbury 415
Nanjing 391
New York 359
Des Moines 276
Bari 255
Dallas 252
Los Angeles 228
Boardman 179
Princeton 177
Rome 177
São Paulo 158
Munich 154
Milan 142
Santa Clara 129
Ho Chi Minh City 124
Buffalo 114
Brooklyn 112
Shenyang 107
Nanchang 101
Inglewood 96
Hebei 95
London 94
San Diego 92
Brussels 89
Dearborn 74
Dong Ket 73
Jiaxing 72
Hanoi 70
Dublin 65
Naples 62
Helsinki 61
Tianjin 60
Changsha 59
Chicago 57
Rio de Janeiro 57
Redwood City 56
Paris 52
Belo Horizonte 51
Council Bluffs 51
Toronto 49
The Dalles 47
Columbus 44
Pune 44
Abidjan 40
Brasília 40
Moscow 40
Turku 40
Florence 39
Jakarta 39
Montreal 39
Tokyo 38
Boston 37
Phoenix 35
Campinas 34
Bologna 33
Warsaw 33
Palermo 32
Johannesburg 31
Curitiba 30
Frankfurt am Main 30
Guangzhou 29
San Francisco 29
Turin 29
Stockholm 28
Atlanta 26
Falls Church 26
Augusta 25
Washington 25
San Mateo 22
Porto Alegre 21
Baghdad 20
Leawood 20
Mexico City 20
Nuremberg 20
Tashkent 20
Buenos Aires 19
Chennai 19
Denver 18
Hefei 18
Ribeirão Preto 17
Bitonto 16
Goiânia 16
Salvador 16
Auburn Hills 15
Manchester 15
Totale 23.275
Nome #
L’INFILTRAZIONE PERINEURALE E LA POSITIVITA’ DEI MARGINI CHIRURGICI NELLA PROGNOSI DEI PAZIENTI CON CARCINOMA PROSTATICO SOTTOPOSTI A PROSTATECTOMIA RADICALE. 1.586
ACCESSO LOMBOTOMICO VS ACCESSO TRANSPERITONEALE NELLA CHIRURGIA DEL CARCINOMA RENALE. RISULTATI PRELIMINARI DI UNO STUDIO RANDOMIZZATO. 643
miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction 229
Renal progenitor cells revert LPS-induced endothelial-to-mesenchymal transition by secreting CXCL6, SAA4, and BPIFA2 antiseptic peptides 203
LE ANASTOMOSI URETERO-INTESTINALI: CONDOTTO ILEALE CON URETERO - ILEOANASTOMOSI SECONDO WALLACE. 200
A 1-year maintenance after early adjuvant intravesical chemotherapy has a limited efficacy in preventing recurrence of intermediate risk non-muscle-invasive bladder cancer. 194
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma. 191
LA FISTOLA CAVERNO-SPONGIOSA SECONDO WINTER NEL TRATTAMENTO DEL PRIAPISMO IDIOPATICO. 189
Loss of STK11 expression is an early event in prostate carcinogenesis and predicts therapeutic response to targeted therapy against MAPK/p38. 184
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma 184
Complement Modulation of Anti-Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function 180
Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml. 179
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 179
Addition of sirolimus to cyclosporine delays the recovery from delayed graft function but does not affect 1-year graft function 174
Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell Carcinoma 170
A single-center cohort study to define the role of pretransplant biopsy score in the long-term outcome of kidney transplantation. 168
Complement component C5a induces aberrant epigenetic modifications in renal tubular epithelial cells accelerating senescence by Wnt4/βcatenin signaling after ischemia/reperfusion injury 166
Isolation and characterization of cancer stem cells in renal cell carcinoma. 165
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 164
Bilateral tumors of the testis in 21-alpha hydroxylase deficiency without adrenal hyperplasia 157
Androgen deprivation therapy affects BCL-2 expression in human prostate cancer 157
Capillary hemangioma of the scrotum mimicking an epididymal tumor: case report. 154
Recurrent urinary tract infections in kidney transplant recipients during the first-year influence long-term graft function: a single-center retrospective cohort study 151
Impact of donor-recipient gender on kidney graft and patient survival: short- and long-term outcomes. 149
Soluble Serum αklotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma 149
Clinical management of a unique case of PNET of the uterus during pregnancy, and review of the literature 149
Complement-dependent NADPH oxidase enzyme activation in renal ischemia/reperfusion injury. 148
Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics 146
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 144
BCG septicemia after radical cystectomy: a rare postoperative complication following BCG therapy 142
Interleukin-27 is a potential marker for the onset of post-transplant malignancies 140
Pre-existing Type 2 Diabetes Mellitus Is an Independent Risk Factor for Mortality and Progression in Patients With Renal Cell Carcinoma. 140
Dysfunctional DC subsets in RCC patients: Ex vivo correction to yield an effective anti-cancer vaccine 139
Experience of percutaneous access under ultrasound guidance in renal transplant patients with allograft lithiasis 139
Complement activation during ischemia/reperfusion injury induces pericyte-to-myofibroblast transdifferentiation regulating peritubular capillary Lumen Reduction Through pERK Signaling 138
ANGIOMIOLIPOMA CALCIFICO DEL RENE. 137
Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients 137
Allograft nephrectomy: what is the best surgical technique? 137
Adherence to EAU guidelines on penile cancer translates into better outcomes: a multicenter international study 136
Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment 136
T helper 1, 2 and 17 cell subsets in renal transplant patients with delayed graft function 135
Predictive value of resistive index in graft survival after kidney transplant. 135
A challenging surgical approach to locally advanced primary urethral carcinoma: A case report and literature review 134
Role of imaging and biopsy to assess local recurrence after definitive treatment for prostate carcinoma 134
Uridine and pyruvate protect T cells’ proliferative capacity from mitochondrial toxic antibiotics: a clinical pilot study 134
Cyclosporin exposure correlates with 1 year graft function and histological damage in renal transplanted patients 133
UROCITOLOGIA E COLPOCITOLOGIA IN CLIMATERIO E NELLA SENILITA' 132
Spondin-2, a Secreted Extracellular Matrix Protein, Is a Novel Diagnostic Biomarker for Prostate Cancer. 132
Extended criteria donor kidney transplantation: comparative outcome analysis between single versus double kidney transplantation at 5 years 132
Allograft nephrectomy: Intracapsular vs extracapsular tecnique 131
Penile prosthesis implant for primary erectile dysfunction in patient with Klippel-Trenaunay syndrome complicated by consumptive coagulopathy: A case report 131
Androgen deprivation therapy regulation of beta 1C integrin expression in prostate cancer 130
Lethal somatostatin analog-induced acute necrotizing pancreatitis in a patient with hormone-refractory prostate cancer 130
Genome-wide analysis of differentially expressed genes and splicing isoforms in clear cell renal cell carcinoma. 129
Penile prosthesis implant: when, what and how 128
Prednisone plus gefitinib versus prednisone plus placebo in the treatment of hormone-refractory prostate cancer: a randomized phase II trial 128
Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer. 128
Repair of vaginal prolapse following penoscrotal flap vaginoplasty in a male-to-female transsexual 127
Advanced age is not an exclusion criterion for kidney transplantation. 127
SERUM SARCOSINE INCREASES THE ACCURACY OF PROSTATE CANCER DETECTION IN LOW RANGE PSA 127
Endothelial-to-Mesenchymal Transition (EndMT) in Swine Renal Ischemia Reperfusion (I/R) Injury Is Mediated by Complement and AKT Pathway 125
Establishment and characterization of a highly immunogenic human renal carcinoma cell line 125
Emerging urinary markers of renal injury in obstructive nephropathy. 124
Spontaneous rupture of an ileal neobladder 6 years after construction 123
VHL gene alterations in Italian patients with isolated renal cell carcinomas 121
Lymph node staging in early prostatic carcinoma with radioguided sentinel node biopsy 121
Single-step surgical tretment of adrenal pheochromocytoma and medullary thyroid carcinoma in Sipple's Syndrome 120
null 119
Penile prosthesis: what should we do about complications? 118
"Deviceless" hand-assisted laparoscopic donor nephrectomy 118
ATTEMPT TO CORRECT IMMUNE DEFICITS IN PATIENTS WITH CHRONIC URINARY-TRACT INFECTION BY ADMINISTRATION OF A THYMIC EXTRACT 118
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer 117
Incidental prostatic cancer: repeat TURP or biopsy? 117
Diagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma. 117
GOSERELIN ACETATE WITH OR WITHOUT FLUTAMIDE IN THE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC PROSTATE-CANCER 116
Kidney transplants from infected donors: Our experience 116
Reperfusion blood pressure as risk, factor for delayed graft function in cadaveric kidney transplant 116
Adherence to the EAU guidelines on Penile Cancer Treatment: European, multicentre, retrospective study 116
Altered p53 and pRb expression is predictive of response to BCG treatment in T1G3 bladder cancer. Anticancer Res. 2009 Oct;29(10):4201-4. PubMed PMID: 19846973 114
Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer 114
Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage 113
Ischemia-reperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: differential modulation by rapamycin 113
Prospective randomized trial comparing high lumbotomic with laparotomic access in renal cell carcinoma surgery 113
Pentraxin-3-mediated complement activation in a swine model of renal ischemia/reperfusion injury 113
Adjuvant hormone therapy after radical prostatectomy: Indications and results 112
DelCFHR3-1 influences graft survival in transplant patients with IgA nephropathy via Complement-mediated cellular senescence 112
Influence of bicalutamide with or without tamoxifen or anastrozole on insulin-like growth factor 1 and binding proteins in prostate cancer patients 111
The three-gene signature in urinary extracellular vesicles from patients with clear cell renal cell carcinoma 111
Medical and surgical complications after kidney transplantation from "suboptimal donors": One centre's experience 111
Early withdrawal of cyclosporine A improves 1-year kidney graft structure and function in sirolimus-treated patients 110
Statin use and survival in patients with metastatic castrationresistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: The international retrospective observational STABEN study 109
Middle and long-term outcomes of dual kidney transplant: a multicenter experience 109
Current insights in renal cell cancer pathology 108
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance 108
ATTEMPT TO CORRECT IMMUNE DEFICITS IN PATIENTS WITH CHRONIC URINARY TRACT INFECTION BY ADMINISTRATION OF A THYMIC EXTRACT. 107
Approccio laparoscopico alla patologia renale 107
True mycotic arteritis by Candida albicans in 2 kidney transplant recipients from the same donor 106
Patient and partner satisfaction after AMS inflatable penile prosthesis implant 106
Double J stent with antireflux device in the prevention of short-term urological complications after cadaveric kidney transplantation: single-center prospective randomized study 105
Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles 105
Totale 15.554
Categoria #
all - tutte 161.020
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 161.020


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.501 0 0 0 0 0 158 390 284 408 523 411 327
2021/20222.909 170 426 52 128 159 180 124 169 168 211 464 658
2022/20234.678 710 418 248 462 538 618 94 508 773 55 139 115
2023/20241.714 201 317 110 112 124 451 57 99 23 51 33 136
2024/20256.565 130 136 610 282 160 562 490 580 271 320 963 2.061
2025/20266.155 2.027 489 722 1.289 1.393 235 0 0 0 0 0 0
Totale 36.788